BACKGROUND: Ocular syphilis is an inflammatory eye disease due to Treponema pallidum infection. In the United States, syphilis rates have increased since 2000; clusters of ocular syphilis were reported in 2015. We investigated ocular syphilis in North Carolina to describe the epidemiology and clinical course of disease. METHODS: We reviewed syphilis cases reported to North Carolina during 2014-2015 and abstracted information from health department interviews for cases with ocular symptoms and no other defined etiology. To assess duration and severity of ocular symptoms, we also reviewed medical records and conducted structured interviews. We compared the prevalence of ocular manifestations among reported syphilis cases by demographic and clinical characteristics. RESULTS: Among 4232 syphilis patients, 63 (1.5%) had ocular syphilis: 21 in 2014 and 42 in 2015, a 100% increase. Total syphilis cases increased 35% through 2015. No patient with ocular syphilis named another ocular syphilis patient as a sex partner. Patients presented in all syphilis stages; 24 (38%) were diagnosed in primary or secondary syphilis. Ocular manifestations were more prevalent among syphilis patients who were male, aged ≥40 years, white, and infected with human immunodeficiency virus. No risk behaviors were associated with ocular syphilis. Among 39 interviewed patients, 34 (87%) reported reduced vision during infection; 12 (31%) reported residual visual symptoms posttreatment. CONCLUSIONS: In North Carolina, ocular syphilis increased from 2014 to 2015 and may be due to increased recognition of ocular manifestations, or a true increase in ocular syphilis. Many ocular syphilis patients experienced vision loss; however, most improved posttreatment. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Ocular syphilis is an inflammatory eye disease due to Treponema pallidum infection. In the United States, syphilis rates have increased since 2000; clusters of ocular syphilis were reported in 2015. We investigated ocular syphilis in North Carolina to describe the epidemiology and clinical course of disease. METHODS: We reviewed syphilis cases reported to North Carolina during 2014-2015 and abstracted information from health department interviews for cases with ocular symptoms and no other defined etiology. To assess duration and severity of ocular symptoms, we also reviewed medical records and conducted structured interviews. We compared the prevalence of ocular manifestations among reported syphilis cases by demographic and clinical characteristics. RESULTS: Among 4232 syphilis patients, 63 (1.5%) had ocular syphilis: 21 in 2014 and 42 in 2015, a 100% increase. Total syphilis cases increased 35% through 2015. No patient with ocular syphilis named another ocular syphilis patient as a sex partner. Patients presented in all syphilis stages; 24 (38%) were diagnosed in primary or secondary syphilis. Ocular manifestations were more prevalent among syphilis patients who were male, aged ≥40 years, white, and infected with human immunodeficiency virus. No risk behaviors were associated with ocular syphilis. Among 39 interviewed patients, 34 (87%) reported reduced vision during infection; 12 (31%) reported residual visual symptoms posttreatment. CONCLUSIONS: In North Carolina, ocular syphilis increased from 2014 to 2015 and may be due to increased recognition of ocular manifestations, or a true increase in ocular syphilis. Many ocular syphilis patients experienced vision loss; however, most improved posttreatment. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
Treponema pallidum; epidemiology; surveillance; syphilis; vision loss
Authors: Julia C Dombrowski; Rolf Pedersen; Christina M Marra; Roxanne P Kerani; Matthew R Golden Journal: Sex Transm Dis Date: 2015-12 Impact factor: 2.830
Authors: Sara Oliver; Sharon K Sahi; Lauren C Tantalo; Charmie Godornes; Robyn Neblett Fanfair; Lauri E Markowitz; Sheila A Lukehart; Christina M Marra Journal: Sex Transm Dis Date: 2016-08 Impact factor: 2.830
Authors: Sara E Oliver; Mark Aubin; Leah Atwell; James Matthias; Anna Cope; Victoria Mobley; Alexandra Goode; Sydney Minnerly; Juliet Stoltey; Heidi M Bauer; Robin R Hennessy; Dawne DiOrio; Robyn Neblett Fanfair; Thomas A Peterman; Lauri Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2016-11-04 Impact factor: 17.586
Authors: Jonathan Z Li; Joseph D Tucker; Ann-Marie Lobo; Christina M Marra; Benjamin T Davis; George N Papaliodis; Donna Felsenstein; Marlene L Durand; Sigal Yawetz; Gregory K Robbins Journal: Clin Infect Dis Date: 2010-08-15 Impact factor: 9.079
Authors: David A Jackson; Robert McDonald; Laura A S Quilter; Hillard Weinstock; Elizabeth A Torrone Journal: Sex Transm Dis Date: 2022-07-13 Impact factor: 3.868
Authors: Emily K Tam; Alexander Port; Diana Martin; Gabrielle Fridman; Steven Ness; Nicole H Siegel Journal: Int J Ophthalmol Date: 2022-08-18 Impact factor: 1.645
Authors: Antonio Junco-Fernández; Madeline C Montgomery; Christina Crowley; Thomas Bertrand; Theodore P Marak; Michaela A Maynard; Caroline Gummo; Timothy P Flanigan; Philip A Chan Journal: R I Med J (2013) Date: 2019-02-01
Authors: Anna B Cope; Victoria L Mobley; Sara E Oliver; Mara Larson; Nicole Dzialowy; Jason Maxwell; Jessica L Rinsky; Thomas A Peterman; Aaron Fleischauer; Erika Samoff Journal: Sex Transm Dis Date: 2019-02 Impact factor: 2.830